A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer

Angelo Tognoni, Roberto Cattaneo, Edgar Serfling, Walter Schaffner

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

We have used a novel approach called expression selection to precisely define the hepatitis B virus (HBV) enhancer. Expression selection is based on a shuttle vector containing an enhancerless SV40 T antigen gene, the SV40 origin of replication and a plasmid replicon. This vector is linearized, ligated with the sonicated DNA to be analyzed and transfected into eukaryotic cells, where only plasmids which have incorporated an enhancer can express T antigen and therefore replicate. Vectors amplified by replication are selectively rescued in E.coli and their inserts analyzed. When we performed this protocol with HBV DNA we rescued two overlapping fragments of 166 and 214 bp which in HBV DNA map about 500 bp upstream of the core antigen mRNA initiation site and 1150 bp downstream of the surface antigen mRNA initiation site. These results were confirmed by conventional deletion mapping. When compared to the SV40 enhancer in nonhepatic cell lines, the HBV enhancer is only 5 to 10% as active; nevertheless, it also acts in an orientation-independent manner and in a position downstream of a gene. The HBV enhancer is situated in the coding region of the potential reverse transcriptase, and thus is the first enhancer identified to map in a protein-coding region.

Original languageEnglish (US)
Pages (from-to)7457-7472
Number of pages16
JournalNucleic Acids Research
Volume13
Issue number20
DOIs
StatePublished - Oct 25 1985
Externally publishedYes

Fingerprint

Viruses
Hepatitis B virus
Virus
Antigens
DNA
Messenger RNA
Replication
Plasmids
Coding
Genes
Gene
Polyomavirus Transforming Antigens
Genetic Vectors
Replicon
Replication Origin
RNA-Directed DNA Polymerase
Viral Tumor Antigens
Cell
Eukaryotic Cells
Surface Antigens

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Health, Toxicology and Mutagenesis
  • Toxicology
  • Genetics(clinical)
  • Genetics

Cite this

A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. / Tognoni, Angelo; Cattaneo, Roberto; Serfling, Edgar; Schaffner, Walter.

In: Nucleic Acids Research, Vol. 13, No. 20, 25.10.1985, p. 7457-7472.

Research output: Contribution to journalArticle

Tognoni, Angelo ; Cattaneo, Roberto ; Serfling, Edgar ; Schaffner, Walter. / A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. In: Nucleic Acids Research. 1985 ; Vol. 13, No. 20. pp. 7457-7472.
@article{5cfe034db4844ca0a4db520dcc1b2566,
title = "A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer",
abstract = "We have used a novel approach called expression selection to precisely define the hepatitis B virus (HBV) enhancer. Expression selection is based on a shuttle vector containing an enhancerless SV40 T antigen gene, the SV40 origin of replication and a plasmid replicon. This vector is linearized, ligated with the sonicated DNA to be analyzed and transfected into eukaryotic cells, where only plasmids which have incorporated an enhancer can express T antigen and therefore replicate. Vectors amplified by replication are selectively rescued in E.coli and their inserts analyzed. When we performed this protocol with HBV DNA we rescued two overlapping fragments of 166 and 214 bp which in HBV DNA map about 500 bp upstream of the core antigen mRNA initiation site and 1150 bp downstream of the surface antigen mRNA initiation site. These results were confirmed by conventional deletion mapping. When compared to the SV40 enhancer in nonhepatic cell lines, the HBV enhancer is only 5 to 10{\%} as active; nevertheless, it also acts in an orientation-independent manner and in a position downstream of a gene. The HBV enhancer is situated in the coding region of the potential reverse transcriptase, and thus is the first enhancer identified to map in a protein-coding region.",
author = "Angelo Tognoni and Roberto Cattaneo and Edgar Serfling and Walter Schaffner",
year = "1985",
month = "10",
day = "25",
doi = "10.1093/nar/13.20.7457",
language = "English (US)",
volume = "13",
pages = "7457--7472",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer

AU - Tognoni, Angelo

AU - Cattaneo, Roberto

AU - Serfling, Edgar

AU - Schaffner, Walter

PY - 1985/10/25

Y1 - 1985/10/25

N2 - We have used a novel approach called expression selection to precisely define the hepatitis B virus (HBV) enhancer. Expression selection is based on a shuttle vector containing an enhancerless SV40 T antigen gene, the SV40 origin of replication and a plasmid replicon. This vector is linearized, ligated with the sonicated DNA to be analyzed and transfected into eukaryotic cells, where only plasmids which have incorporated an enhancer can express T antigen and therefore replicate. Vectors amplified by replication are selectively rescued in E.coli and their inserts analyzed. When we performed this protocol with HBV DNA we rescued two overlapping fragments of 166 and 214 bp which in HBV DNA map about 500 bp upstream of the core antigen mRNA initiation site and 1150 bp downstream of the surface antigen mRNA initiation site. These results were confirmed by conventional deletion mapping. When compared to the SV40 enhancer in nonhepatic cell lines, the HBV enhancer is only 5 to 10% as active; nevertheless, it also acts in an orientation-independent manner and in a position downstream of a gene. The HBV enhancer is situated in the coding region of the potential reverse transcriptase, and thus is the first enhancer identified to map in a protein-coding region.

AB - We have used a novel approach called expression selection to precisely define the hepatitis B virus (HBV) enhancer. Expression selection is based on a shuttle vector containing an enhancerless SV40 T antigen gene, the SV40 origin of replication and a plasmid replicon. This vector is linearized, ligated with the sonicated DNA to be analyzed and transfected into eukaryotic cells, where only plasmids which have incorporated an enhancer can express T antigen and therefore replicate. Vectors amplified by replication are selectively rescued in E.coli and their inserts analyzed. When we performed this protocol with HBV DNA we rescued two overlapping fragments of 166 and 214 bp which in HBV DNA map about 500 bp upstream of the core antigen mRNA initiation site and 1150 bp downstream of the surface antigen mRNA initiation site. These results were confirmed by conventional deletion mapping. When compared to the SV40 enhancer in nonhepatic cell lines, the HBV enhancer is only 5 to 10% as active; nevertheless, it also acts in an orientation-independent manner and in a position downstream of a gene. The HBV enhancer is situated in the coding region of the potential reverse transcriptase, and thus is the first enhancer identified to map in a protein-coding region.

UR - http://www.scopus.com/inward/record.url?scp=0022432508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022432508&partnerID=8YFLogxK

U2 - 10.1093/nar/13.20.7457

DO - 10.1093/nar/13.20.7457

M3 - Article

C2 - 2997748

AN - SCOPUS:0022432508

VL - 13

SP - 7457

EP - 7472

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 20

ER -